NF-κB activation in myeloid cells mediates ventilator-induced lung injury

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Ko, Yi An ^a   Yang, Ming Chieh ^b   Huang, Hung Tu ^c   Hsu, Ching Mei ^a   Chen, Lee Wei ^b,d  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Alveolar macrophage; Chimeric mice; IL 6; Inflammation; Mechanical ventilator; NF B

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; INTERLEUKIN 6, MOUSE; INTERLEUKIN-6, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CAPILLARY PERMEABILITY; CONTROLLED STUDY; LUNG CAPILLARY; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; TIDAL VOLUME; VENTILATOR; VENTILATOR INDUCED LUNG INJURY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGY; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS; NF-KAPPA B; VENTILATOR-INDUCED LUNG INJURY;

EID: 84879826026     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-69     Document Type: Article

References (28)

1. Budweiser S, Jorres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis 2008, 3(4):605-618. 2650592, 19281077.
2. Dhanireddy S, Altemeier WA, Matute-Bello G, O'Mahony DS, Glenny RW, Martin TR, Liles WC. Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest 2006, 86(8):790-799. 10.1038/labinvest.3700440, 16855596.
3. Damarla M, Hasan E, Boueiz A, Le A, Pae HH, Montouchet C, Kolb T, Simms T, Myers A, Kayyali US, et al. Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury. PLoS One 2009, 4(2):e4600. 10.1371/journal.pone.0004600, 2643011, 19240800.
4. Frank JA, Pittet JF, Wray C, Matthay MA. Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade. Thorax 2008, 63(2):147-153.
5. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999, 159(4 Pt 1):1249-1256.
6. Halbertsma FJ, Vaneker M, Scheffer GJ, van der Hoeven JG. Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med 2005, 63(10):382-392.
7. Dolinay T, Wu W, Kaminski N, Ifedigbo E, Kaynar AM, Szilasi M, Watkins SC, Ryter SW, Hoetzel A, Choi AM. Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS One 2008, 3(2):e1601. 10.1371/journal.pone.0001601, 2223071, 18270588.
8. Wolters PJ, Wray C, Sutherland RE, Kim SS, Koff J, Mao Y, Frank JA. Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol 2009, 182(12):8056-8062. 10.4049/jimmunol.0801323, 2737530, 19494331.
9. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990, 10(5):2327-2334. 360580, 2183031.
10. Srivastava SK, Ramana KV. Focus on molecules: nuclear factor-kappaB. Exp Eye Res 2009, 88(1):2-3. 10.1016/j.exer.2008.03.012, 2606916, 18472097.
11. Liu YY, Liao SK, Huang CC, Tsai YH, Quinn DA, Li LF. Role for nuclear factor-kappaB in augmented lung injury because of interaction between hyperoxia and high stretch ventilation. Transl Res 2009, 154(5):228-240. 10.1016/j.trsl.2009.06.006, 19840764.
12. Held HD, Boettcher S, Hamann L, Uhlig S. Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids. Am J Respir Crit Care Med 2001, 163(3 Pt 1):711-716.
13. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005, 175(6):3463-3468.
14. Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997, 85(1):16-20. 10.1006/clin.1997.4420, 9325064.
15. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA. Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000, 22(5):535-542. 10.1165/ajrcmb.22.5.3808, 10783124.
16. Frank JA, Parsons PE, Matthay MA. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006, 130(6):1906-1914. 10.1378/chest.130.6.1906, 2764530, 17167015.
17. Ramirez P, Ferrer M, Gimeno R, Tormo S, Valencia M, Piner R, Menendez R, Torres A. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med 2009, 37(5):1691-1695. 10.1097/CCM.0b013e31819fec5f, 19325465.
18. Jones SA, Rose-John S. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta 2002, 1592(3):251-263. 10.1016/S0167-4889(02)00319-1, 12421670.
19. Hegeman MA, Hennus MP, Heijnen CJ, Specht PA, Lachmann B, Jansen NJ, van Vught AJ, Cobelens PM. Ventilator-induced endothelial activation and inflammation in the lung and distal organs. Crit Care 2009, 13(6):R182. 10.1186/cc8168, 2811914, 19917112.
20. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, Goktuna SI, Neuenhahn M, Fierer J, Paxian S, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007, 130(5):918-931. 10.1016/j.cell.2007.07.009, 2134986, 17803913.
21. Patterson CE, Rhoades RA, Garcia JG. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol 1992, 72(3):865-873. 10.1063/1.351760, 1568982.
22. Renckens R, van Westerloo DJ, Roelofs JJ, Pater JM, Schultz MJ, Florquin S, van der Poll T. Acute phase response impairs host defense against pseudomonas aeruginosa pneumonia in mice. Crit Care Med 2008, 36(2):580-587. 10.1097/01.CCM.0B013E3181620652, 18091542.
23. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, Grivennikov S, Wynshaw-Boris A, Scadeng M, Olefsky JM, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007, 6(5):386-397. 10.1016/j.cmet.2007.09.011, 17983584.
24. Takata M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, Miyasaka K. Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med 1997, 156(1):272-279. 10.1164/ajrccm.156.1.9607072, 9230760.
25. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998, 338(6):347-354. 10.1056/NEJM199802053380602, 9449727.
26. Oeckler RA, Hubmayr RD. Ventilator-associated lung injury: a search for better therapeutic targets. Eur Respir J 2007, 30(6):1216-1226. 10.1183/09031936.00104907, 18055706.
27. Hsu LC, Enzler T, Seita J, Timmer AM, Lee CY, Lai TY, Yu GY, Lai LC, Temkin V, Sinzig U, et al. IL-1beta-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKbeta. Nat Immunol 2011, 12(2):144-150. 10.1038/ni.1976, 3677078, 21170027.
28. Liang B, Song Z, Wu B, Gardner D, Shealy D, Song XY, Wooley PH. Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis. J Inflamm (Lond) 2009, 6:10.